Protocol No
JNJ-68284528MMY3004CARTITUDE-5
Phase
III
Summary
The purpose of this study is to see if VRd followed by cilta-cel is safe and useful for treating
patients with newly diagnosed Multiple Myeloma, as compared with the use of VRd followed by Rd therapy.
Description
CAR-T Clinical trial in Subjects with Newly Diagnosed MM and for Whom HSCT is not planned
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
ClinicalTrials.gov